Drug intelligence / Profile preview

Pentabiocel

Development stage: Preclinical
Lead developer: SACCO SYSTEM
Modality: Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics
Administration: Oral

Overview

Pentabiocel is a patented blend of five probiotic strains, specifically formulated as a food supplement to promote the balance of intestinal bacterial flora. The formulation contains two strains of Lactobacillus (Lactobacillus paracasei 101/37 LMG P-17504 and Lactobacillus plantarum 14D CECT 4528) and three strains of Bifidobacterium (Bifidobacterium breve Bbr8 LMG P-17501, Bifidobacterium breve BL10 LMG P-17500, and Bifidobacterium animalis subsp. lactis Bi1 LMG P-17502). Scientific research indicates that these probiotics can survive gastric passage and colonize the intestine alive and active. Clinical studies suggest that Pentabiocel may be beneficial for individuals with celiac disease or gluten sensitivity by improving symptoms related to intestinal dysbiosis, which is common in these conditions[1][2][4]. It is available as an oral powder in stick packs.

Brand names: Pentabiocel
Other names: Pentabiocel

Beyond the preview

Go deeper on Pentabiocel.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pentabiocel.

Explore the full profile